| Primary |
| Chronic Obstructive Pulmonary Disease |
57.7% |
| Asthma |
12.7% |
| Emphysema |
4.5% |
| Interstitial Lung Disease |
4.5% |
| Hypertension |
3.6% |
| Pulmonary Fibrosis |
2.7% |
| Constipation |
1.4% |
| Dyspnoea |
1.4% |
| Respiratory Failure |
1.4% |
| Antiplatelet Therapy |
0.9% |
| Cerebral Infarction |
0.9% |
| Diffuse Panbronchiolitis |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Hyperlipidaemia |
0.9% |
| Hypothyroidism |
0.9% |
| Prophylaxis |
0.9% |
| Psoriatic Arthropathy |
0.9% |
| Salivary Hypersecretion |
0.9% |
| Smoking Cessation Therapy |
0.9% |
| Supraventricular Tachycardia |
0.9% |
|
| Ventricular Extrasystoles |
12.9% |
| Death |
11.4% |
| Chronic Obstructive Pulmonary Disease |
8.6% |
| Urinary Retention |
8.6% |
| Drug Ineffective |
7.1% |
| Cerebrovascular Disorder |
5.7% |
| Electrocardiogram Qt Prolonged |
5.7% |
| Supraventricular Extrasystoles |
4.3% |
| Syncope |
4.3% |
| Alanine Aminotransferase Increased |
2.9% |
| Angle Closure Glaucoma |
2.9% |
| Arrhythmia |
2.9% |
| Arteriosclerosis |
2.9% |
| Diffuse Panbronchiolitis |
2.9% |
| Dyspnoea |
2.9% |
| Fatigue |
2.9% |
| Lung Neoplasm |
2.9% |
| Pneumonia |
2.9% |
| Productive Cough |
2.9% |
| Respiratory Failure |
2.9% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
32.9% |
| Drug Use For Unknown Indication |
21.1% |
| Product Used For Unknown Indication |
9.7% |
| Asthma |
6.7% |
| Hypertension |
5.3% |
| Emphysema |
4.9% |
| Suicide Attempt |
2.3% |
| Depression |
1.9% |
| Pain |
1.9% |
| Sinusitis |
1.9% |
| Atrial Fibrillation |
1.4% |
| Bronchitis |
1.4% |
| Prophylaxis |
1.4% |
| Restless Legs Syndrome |
1.4% |
| Hiv Infection |
1.2% |
| Antiplatelet Therapy |
0.9% |
| Constipation |
0.9% |
| Hypothyroidism |
0.9% |
| Salivary Hypersecretion |
0.9% |
| Urinary Retention |
0.9% |
|
| Subdural Haematoma |
15.3% |
| Urinary Retention |
8.5% |
| Wheezing |
8.5% |
| Chronic Obstructive Pulmonary Disease |
5.1% |
| Fall |
5.1% |
| Lower Respiratory Tract Infection |
5.1% |
| Pulmonary Embolism |
5.1% |
| Stress Cardiomyopathy |
5.1% |
| Tonic Convulsion |
5.1% |
| Cardiac Failure Congestive |
3.4% |
| Completed Suicide |
3.4% |
| Death |
3.4% |
| Drug Ineffective |
3.4% |
| Nausea |
3.4% |
| Neuroleptic Malignant Syndrome |
3.4% |
| Osteoporosis |
3.4% |
| Oxygen Saturation Decreased |
3.4% |
| Pneumonia |
3.4% |
| Prinzmetal Angina |
3.4% |
| Transient Ischaemic Attack |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
43.2% |
| Drug Use For Unknown Indication |
15.6% |
| Chronic Obstructive Pulmonary Disease |
11.7% |
| Asthma |
4.1% |
| Hypertension |
3.6% |
| Pain |
3.0% |
| Prophylaxis |
3.0% |
| Rheumatoid Arthritis |
2.6% |
| Osteoporosis |
2.2% |
| Non-small Cell Lung Cancer |
1.6% |
| Hepatitis C |
1.5% |
| Depression |
1.4% |
| Atrial Fibrillation |
1.2% |
| Diabetes Mellitus |
1.0% |
| Type 2 Diabetes Mellitus |
0.9% |
| Breast Cancer |
0.7% |
| Schizophrenia |
0.7% |
| Anaemia |
0.7% |
| Constipation |
0.7% |
| Prostate Cancer |
0.7% |
|
| Vomiting |
12.1% |
| Death |
9.6% |
| Tremor |
6.7% |
| Wheezing |
6.4% |
| Dyspnoea |
5.7% |
| Pyrexia |
5.7% |
| Weight Decreased |
5.7% |
| White Blood Cell Count Increased |
5.1% |
| Renal Failure Acute |
4.5% |
| Respiratory Failure |
4.5% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Pneumonia |
3.8% |
| Sepsis |
3.8% |
| Urinary Tract Infection |
3.8% |
| Myocardial Infarction |
3.5% |
| International Normalised Ratio Increased |
3.2% |
| Thrombocytopenia |
3.2% |
| Hyponatraemia |
2.9% |
| Liver Function Test Abnormal |
2.9% |
| Lung Adenocarcinoma |
2.9% |
|
